These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38500408)

  • 1. A Comprehensive Examination of Heterocyclic Scaffold Chemistry for Antitubercular Activity.
    Bendi A; Yadav P; Saini K; Singh Bhathiwal A; Raghav N
    Chem Biodivers; 2024 May; 21(5):e202400067. PubMed ID: 38500408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds.
    Nefzi A; Appel J; Arutyunyan S; Houghten RA
    Bioorg Med Chem Lett; 2009 Sep; 19(17):5169-75. PubMed ID: 19632841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyridazines 91. Synthesis of substituted tri- and tetracyclic compounds bearing a pyridazine core and their biological evaluation as antimycobacterial agents.
    Heinisch G; Matuszczak B; Planitzer K
    Arch Pharm (Weinheim); 2000 Jul; 333(7):231-40. PubMed ID: 10965598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent advances in the research of heterocyclic compounds as antitubercular agents.
    Yan M; Ma S
    ChemMedChem; 2012 Dec; 7(12):2063-75. PubMed ID: 23042656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitubercular activity of heterocycle substituted diphenyl ether derivatives.
    Kini SG; Bhat A; Pan Z; Dayan FE
    J Enzyme Inhib Med Chem; 2010 Oct; 25(5):730-6. PubMed ID: 20443682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antimycobacterial activity of fluorenizid salts].
    Zarichna OZ
    Mikrobiol Z; 2007; 69(5):65-9. PubMed ID: 18217356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
    Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
    Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fragment Discovery for the Design of Nitrogen Heterocycles as Mycobacterium tuberculosis Dihydrofolate Reductase Inhibitors.
    Shelke RU; Degani MS; Raju A; Ray MK; Rajan MG
    Arch Pharm (Weinheim); 2016 Aug; 349(8):602-13. PubMed ID: 27320965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinoline Derivatives as Promising Scaffolds for Antitubercular Activity: A Comprehensive Review.
    Owais M; Kumar A; Hasan SM; Singh K; Azad I; Hussain A; Suvaiv ; Akil M
    Mini Rev Med Chem; 2024; 24(13):1238-1251. PubMed ID: 38185891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, Synthesis and Pharmacological Evaluation of Some C
    Niveditha N; Begum M; Prathibha D; Sirisha K; Mahender P; Chitra C; Rao VR; Reddy VM; Achaiah G
    Chem Pharm Bull (Tokyo); 2020; 68(12):1170-1177. PubMed ID: 33268649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scaffold-switching: an exploration of 5,6-fused bicyclic heteroaromatics systems to afford antituberculosis activity akin to the imidazo[1,2-a]pyridine-3-carboxylates.
    Moraski GC; Oliver AG; Markley LD; Cho S; Franzblau SG; Miller MJ
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3493-8. PubMed ID: 24909079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tubercular activity of novel class of spiropyrrolidine tethered indenoquinoxaline heterocyclic hybrids.
    Arumugam N; Almansour AI; Suresh Kumar R; Ibrahim Alaqeel S; Siva Krishna V; Sriram D
    Bioorg Chem; 2020 Jun; 99():103799. PubMed ID: 32247109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Characterization of N-Oxide-Containing Heterocycles with in Vivo Sterilizing Antitubercular Activity.
    Dos Santos Fernandes GF; de Souza PC; Moreno-Viguri E; Santivañez-Veliz M; Paucar R; Pérez-Silanes S; Chegaev K; Guglielmo S; Lazzarato L; Fruttero R; Man Chin C; da Silva PB; Chorilli M; Solcia MC; Ribeiro CM; Silva CSP; Marino LB; Bosquesi PL; Hunt DM; de Carvalho LPS; de Souza Costa CA; Cho SH; Wang Y; Franzblau SG; Pavan FR; Dos Santos JL
    J Med Chem; 2017 Oct; 60(20):8647-8660. PubMed ID: 28968083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and antimycobacterial activity of some new 3-heterocyclic substituted chromones.
    Gasparová R; Lácová M; el-Shaaer HM; Odlerová Z
    Farmaco; 1997 Apr; 52(4):251-3. PubMed ID: 9241831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and antimycobacterial activity of some new pyridazine derivatives: bis-pyridazine. Part IV.
    Mantu D; Antoci V; Mangalagiu II
    Infect Disord Drug Targets; 2013 Oct; 13(5):344-51. PubMed ID: 24552228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent progress on pyrazole scaffold-based antimycobacterial agents.
    Keri RS; Chand K; Ramakrishnappa T; Nagaraja BM
    Arch Pharm (Weinheim); 2015 May; 348(5):299-314. PubMed ID: 25820461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent progress in the drug development of coumarin derivatives as potent antituberculosis agents.
    Keri RS; Sasidhar BS; Nagaraja BM; Santos MA
    Eur J Med Chem; 2015 Jul; 100():257-69. PubMed ID: 26112067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.